Cutis Laxa (Elastolysis) Treatment & Management

1. Kumar P, Savant SS, Das A. Generalized acquired cutis laxa type 1: a case report and brief review of literature. Dermatol Online J. 2016 Mar 16. 22 (3):[QxMD MEDLINE Link].

2. Morava E, Lefeber DJ, Urban Z, et al. Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur J Hum Genet. 2008 Jan. 16(1):28-35. [QxMD MEDLINE Link].

3. Loeys B, Van Maldergem L, Mortier G, et al. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet. 2002 Sep 1. 11(18):2113-8. [QxMD MEDLINE Link].

4. University of Pittsburgh Dept. of Human Genetics. What are the different types of cutis laxa?. Cutis Laxa Research Study. Available at http://cutislaxa.pitt.edu/faq.php#diff. Accessed: March 4, 2022.

5. Callewaert BL, Urban Z, Adam MP, Ardinger HH, Pagon RA, Wallace SE, et al. LTBP4-Related Cutis Laxa. 2021 July 22. [QxMD MEDLINE Link]. [Full Text].

6. Morava E, Guillard M, Lefeber DJ, Wevers RA. Autosomal recessive cutis laxa syndrome revisited. Eur J Hum Genet. 2009 Sep. 17 (9):1099-110. [QxMD MEDLINE Link]. [Full Text].

7. Van Maldergem L, Dobyns W, Kornak U, Adam MP, Ardinger HH, Pagon RA, et al. ATP6V0A2-Related Cutis Laxa. 2021 January 28. [QxMD MEDLINE Link]. [Full Text].

8. Hennies HC, Kornak U, Zhang H, et al. Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin. Nat Genet. 2008 Dec. 40 (12):1410-2. [QxMD MEDLINE Link]. [Full Text].

9. Graul-Neumann LM, Hausser I, Essayie M, Rauch A, Kraus C. Highly variable cutis laxa resulting from a dominant splicing mutation of the elastin gene. Am J Med Genet A. 2008 Apr 15. 146A(8):977-83. [QxMD MEDLINE Link].

10. Nygaard RH, Maynard S, Schjerling P, Kjaer M, Qvortrup K, Bohr VA, et al. Acquired Localized Cutis Laxa due to Increased Elastin Turnover. Case Rep Dermatol. 2016 Jan-Apr. 8 (1):42-51. [QxMD MEDLINE Link].

11. Jagati A, Shrivastava S, Baghela B, et al. Acquired cutis laxa secondary to Sweet syndrome in a child (Marshall syndrome): A rare case report. J Cutan Pathol. 2020 Feb. 47 (2):146-149. [QxMD MEDLINE Link].

12. Tamura BM, Lourenço LM, Platt A, Pertel P, Santos LF, Levites J. Cutis laxa: Improvement of facial aesthetics by using botulinum toxin. Dermatol Surg. 2004 Dec. 30(12 Pt 2):1518-20. [QxMD MEDLINE Link].

13. Van Maldergem L, Loeys B, Pagon RA, Adam MP, Ardinger HH, Wallace SE, et al. FBLN5-Related Cutis Laxa. 1993. [QxMD MEDLINE Link]. [Full Text].

14. Khakoo A, Thomas R, Trompeter R, Duffy P, Price R, Pope FM. Congenital cutis laxa and lysyl oxidase deficiency. Clin Genet. 1997 Feb. 51(2):109-14. [QxMD MEDLINE Link].

15. Callewaert BL, Urban Z, Pagon RA, Adam MP, Ardinger HH, Wallace SE, et al. LTBP4-Related Cutis Laxa. 1993. [QxMD MEDLINE Link]. [Full Text].

16. Nozaki F, Kusunoki T, Okamoto N, Yamamoto Y, Miya F, Tsunoda T, et al. ALDH18A1-related cutis laxa syndrome with cyclic vomiting. Brain Dev. 2016 Aug. 38 (7):678-84. [QxMD MEDLINE Link].

17. Vajdi T, Lee WW, Paravar T. Penicillamine-associated cutis laxa and milia en plaque - case report and review of cutaneous changes associated with penicillamine. Dermatol Online J. 2016 May 15. 22 (5):[QxMD MEDLINE Link].

18. Hill VA, Seymour CA, Mortimer PS. Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease. Br J Dermatol. 2000 Mar. 142(3):560-1. [QxMD MEDLINE Link].

19. Gonzalez-Rodriguez AJ, Bella-Navarro R, Ramon Quiles D, Jorda-Cuevas E. [Acquired cutis laxa associated with monoclonal gammopathy and lambda light chain deposition disease]. Dermatol Online J. 2014 May 16. 20(5):22611. [QxMD MEDLINE Link].

20. New HD, Callen JP. Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-? and IgA-? gammopathy following treatment of a nodal plasmacytoma. Arch Dermatol. 2011 Mar. 147(3):323-8. [QxMD MEDLINE Link].

21. O'Malley JT, D'Agati VD, Sherman WH, Grossman ME. Acquired Cutis Laxa Associated With Heavy Chain Deposition Disease Involving Dermal Elastic Fibers. JAMA Dermatol. 2014 Aug 13. [QxMD MEDLINE Link].

22. Koklu E, Gunes T, Ozturk MA, Akcakus M, Buyukkayhan D, Kurtoglu S. Cutis laxa associated with central hypothyroidism owing to isolated thyrotropin deficiency in a newborn. Pediatr Dermatol. 2007 Sep-Oct. 24(5):525-8. [QxMD MEDLINE Link].

23. Anderson CE, Finklestein JZ, Nussbaum E, Larson EJ, Halpern R, Uitto J, et al. Association of hemolytic anemia and early-onset pulmonary emphysema in three siblings. J Pediatr. 1984 Aug. 105(2):247-51. [QxMD MEDLINE Link].

24. Alehossein M, Pourgholami M, Kamrani K, Soltani M, Yazdi A, Salamati P. Radiologic findings in cutis laxa syndrome and unusual association with hypertrophic pyloric stenosis. Iran J Radiol. 2013 Jun. 10(2):94-8. [QxMD MEDLINE Link]. [Full Text].

25. Bharadwaj S, Shrestha P, Gohel TD, Singh M. Cutis laxa presenting as recurrent ileus. Gastroenterol Rep (Oxf). 2014 Jul 9. [QxMD MEDLINE Link].

26. Lewis FM, Lewis-Jones S, Gipson M. Acquired cutis laxa with dermatitis herpetiformis and sarcoidosis. J Am Acad Dermatol. 1993 Nov. 29(5 Pt 2):846-8. [QxMD MEDLINE Link].

27. Ting HC, Foo MH, Wang F. Acquired cutis laxa and multiple myeloma. Br J Dermatol. 1984 Mar. 110(3):363-7. [QxMD MEDLINE Link].

28. McCarty MJ, Davidson JM, Cardone JS, Anderson LL. Cutis laxa acquisita associated with multiple myeloma: a case report and review of the literature. Cutis. 1996 Apr. 57(4):267-70. [QxMD MEDLINE Link].

29. Gupta A, Helm TN. Acquired cutis laxa associated with multiple myeloma. Cutis. 2002 Feb. 69(2):114-8. [QxMD MEDLINE Link].

30. Newton JA, McKee PH, Black MM. Cutis laxa associated with amyloidosis. Clin Exp Dermatol. 1986 Jan. 11(1):87-91. [QxMD MEDLINE Link].

31. Tan S, Pon K, Bargman J, Ghazarian D. Generalized cutis laxa associated with heavy chain deposition disease. J Cutan Med Surg. 2003 Sep-Oct. 7(5):390-4. [QxMD MEDLINE Link].

32. Kariminejad A, Afroozan F, Bozorgmehr B, Ghanadan A, Akbaroghli S, Khorram Khorshid HR, et al. Discriminative Features in Three Autosomal Recessive Cutis Laxa Syndromes: Cutis Laxa IIA, Cutis Laxa IIB, and Geroderma Osteoplastica. Int J Mol Sci. 2017 Mar 15. 18 (3):[QxMD MEDLINE Link].

33. Renard M, Holm T, Veith R, Callewaert BL, Adès LC, Baspinar O, et al. Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur J Hum Genet. 2010 Aug. 18(8):895-901. [QxMD MEDLINE Link]. [Full Text].

34. Rajab A, Kornak U, Budde BS, Hoffmann K, Jaeken J, Nurnberg P, et al. Geroderma osteodysplasticum hereditaria and wrinkly skin syndrome in 22 patients from Oman. Am J Med Genet A. 2008 Apr 15. 146A(8):965-76. [QxMD MEDLINE Link].

35. Rao BK, Endzweig CH, Kagen MH, Kriegel D, Freeman RG. Wrinkling due to mid-dermal elastolysis: two cases and literature review. J Cutan Med Surg. 2000 Jan. 4(1):40-4. [QxMD MEDLINE Link].

36. Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg. 2008 Jul-Aug. 24(4):302-7. [QxMD MEDLINE Link].

37. Gupta N, Phadke SR. Cutis laxa type II and wrinkly skin syndrome: distinct phenotypes. Pediatr Dermatol. 2006 May-Jun. 23(3):225-30. [QxMD MEDLINE Link].

38. Mohamed M, Kouwenberg D, Gardeitchik T, Kornak U, Wevers RA, Morava E. Metabolic cutis laxa syndromes. J Inherit Metab Dis. 2011 Aug. 34 (4):907-16. [QxMD MEDLINE Link].

39. Gu W, Liu W, Yang X, Yuan X, Tian Y, Meng R, et al. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry. Eur J Dermatol. 2011 Sep-Oct. 21(5):717-21. [QxMD MEDLINE Link].

Marc Zachary Handler, MD Fellow in Mohs Micrographic Surgery, Skin Laser and Surgery Specialists of NY and NJ

Marc Zachary Handler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, European Society for Pediatric Dermatology, International Society of Dermatology, New York Academy of Medicine, Sigma Xi, The Scientific Research Honor Society, Society for Pediatric Dermatology

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Van Perry, MD Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas School of Medicine at San Antonio

Van Perry, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Daniel J Hogan, MD Clinical Professor of Internal Medicine (Dermatology), Nova Southeastern University College of Osteopathic Medicine; Investigator, Hill Top Research, Florida Research Center

Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, Canadian Dermatology Association

Disclosure: Nothing to disclose.

Susan M Swetter, MD Director, Pigmented Lesion and Melanoma Program, Professor, Department of Dermatology, Stanford University Medical Center and Cancer Institute, Veterans Affairs Palo Alto Health Care System

Susan M Swetter, MD is a member of the following medical societies: American Academy of Dermatology, Women's Dermatologic Society, American Society of Clinical Oncology, Society for Melanoma Research, Eastern Cooperative Oncology Group, American Medical Association, Pacific Dermatologic Association, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Tina Molis, MD, PhD Staff Physician, Department of Radiology, St Francis Medical Center, University of Illinois at Peoria

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article